Stenting as monotherapy for uncoilable intracranial aneurysms.
Publication/Presentation Date
9-1-2013
Abstract
BACKGROUND: Small, blister-like aneurysms (BLAs), by virtue of their unique morphology, are difficult to treat with conventional modalities. The use of oversized self-expanding stents as monotherapy for BLAs is a relatively new and promising concept that warrants further investigation.
OBJECTIVE: To clarify the role of oversized self-expanding stents as monotherapy for BLAs.
METHODS: Five consecutive patients were treated for BLAs with oversized self-expanding stents alone by the senior author (K.R.B.). We report on their clinical and radiographic outcomes.
RESULTS: All 5 patients in our series were discharged in good clinical condition. Complete aneurysm occlusion was observed in all patients at the time of most recent radiographic follow-up. Mean follow-up time was 13.6 months (range, 1 month to 4.5 years).
CONCLUSION: The use of oversized self-expanding stents to redirect flow away from aneurysms is an effective option for patients with BLAs. This approach represents an alternative to the use of flow diverters.
Volume
73
Issue
1 Suppl Operative
First Page
80
Last Page
85
ISSN
1524-4040
Published In/Presented At
Bulsara, K. R., Kuzmik, G. A., Hebert, R., Cheung, V., Matouk, C. C., Jabbour, P., Hasan, D., & Pepper, J. (2013). Stenting as monotherapy for uncoilable intracranial aneurysms. Neurosurgery, 73(1 Suppl Operative), ons80–ons85. https://doi.org/10.1227/NEU.0b013e31827fcaba
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
23208063
Department(s)
Administration and Leadership
Document Type
Article